Skip to content

Clinical Research for the Treatment of Partial Rotator Cuff Tears.

Randomized Clinical Trial for the Treatment of Partial Rotator Cuff Tears.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3rp7qz6
Enrollment
51
Registered
2026-05-13
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Injuries Shoulder Injuries

Interventions

This is a randomized, controlled, double-blind clinical trial, approved by the Research Ethics Committee of the University of Taubaté (CAAE No. 81230824.5.0000.5501). The primary objective is to evalu
50% thickness through subacromial infiltration. Fifty-one participants, men or women, older than 18 years, with persistent shoulder pain for more than 3 months and a diagnosis of partial rotator cuff
50% confirmed by magnetic resonance imaging will be included. Patients with complete or partial rotator cuff tears &gt
50%, traumatic injuries or those related to previous fractures, previous shoulder surgery or infiltration in the last 6 months, other associated painful shoulder pathologies (osteoarthritis, calcific
Aplio-a&quot
linear transducer). The procedure will follow standardized sterile techniques, with local anesthesia (3ml of 1% lidocaine) p

Sponsors

Universidade de Taubaté
Lead Sponsor
Universidade de Taubaté
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Men and women over 18 years of age will be included; those with persistent shoulder pain for more than 3 months; and those with magnetic resonance imaging showing a partial rotator cuff tear of less than 50% of its thickness

Exclusion criteria

Exclusion criteria: Patients with complete or partial rotator cuff tears greater than 50%; lesions secondary to previous trauma or fracture; patients who have undergone previous surgery on the affected shoulder or who have undergone previous shoulder infiltration in the last 6 months; patients with other associated causes of painful shoulder pathology such as osteoarthritis, calcific tendinitis, frozen shoulder; patients with active infections; pregnant women; and patients using immunosuppressants or chronic corticosteroid therapy will be excluded from this study

Design outcomes

Primary

MeasureTime frame
Pain criteria will be assessed using the Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
Functional and quality of life assessment will be performed using the Constant-Murley functional score.;Functional and quality of life assessment will be performed using the American Shoulder and Elbow Surgeons (ASES) functional score.

Countries

BR

Contacts

Public ContactFlávio Leite

Universidade de Taubaté

flavio.sfleite@unitau.br+55-12-997291505

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 11, 2026